Skip to content
10-Q

Quarterly Report

Viemed Healthcare, Inc. VMD

0001729149-26-000029

← back to feed
Filed
May 5, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Apr 29, 2026 38.34M sh
Shares Diluted Q1 2026 · Mar 31, 2026 40.49M sh
Shares Diluted Q1 2026 · Mar 31, 2025 41.63M sh
Stock Repurchased Q1 2026 · Mar 31, 2026 $1.44M
Stock Repurchased Q1 2026 · Mar 31, 2025 $0
Capex Q1 2026 · Mar 31, 2026 $6.71M
Capex Q1 2026 · Mar 31, 2025 $15.48M
Operating Cash Flow Q1 2026 · Mar 31, 2026 $8.07M
Operating Cash Flow Q1 2026 · Mar 31, 2025 $2.85M
Long Term Debt Q1 2026 · Mar 31, 2026 $8.33M
Long Term Debt Q1 2026 · Dec 31, 2025 $11.29M
Short Term Debt Q1 2026 · Mar 31, 2026 $871K
Short Term Debt Q1 2026 · Dec 31, 2025 $1.09M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $9.76M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $13.5M
Stockholders Equity Q1 2026 · Mar 31, 2026 $143.86M
Stockholders Equity Q1 2026 · Dec 31, 2025 $141.55M
Current Liabilities Q1 2026 · Mar 31, 2026 $40.71M
Current Liabilities Q1 2026 · Dec 31, 2025 $41.06M
Total Liabilities Q1 2026 · Mar 31, 2026 $51.57M
Total Liabilities Q1 2026 · Dec 31, 2025 $55.63M
Current Assets Q1 2026 · Mar 31, 2026 $49.81M
Current Assets Q1 2026 · Dec 31, 2025 $48.49M
Total Assets Q1 2026 · Mar 31, 2026 $197.36M
Total Assets Q1 2026 · Dec 31, 2025 $199.15M
Eps Diluted Q1 2026 · Mar 31, 2026 $0.06
Eps Diluted Q1 2026 · Mar 31, 2025 $0.06
Eps Basic Q1 2026 · Mar 31, 2026 $0.07
Eps Basic Q1 2026 · Mar 31, 2025 $0.07
Sga Expense Q1 2026 · Mar 31, 2026 $34.79M
Sga Expense Q1 2026 · Mar 31, 2025 $28.43M
Rd Expense Q1 2026 · Mar 31, 2026 $579K
Rd Expense Q1 2026 · Mar 31, 2025 $797K
Net Income Q1 2026 · Mar 31, 2026 $2.58M
Net Income Q1 2026 · Mar 31, 2025 $2.63M
Operating Income Q1 2026 · Mar 31, 2026 $4.3M
Operating Income Q1 2026 · Mar 31, 2025 $3.84M
Gross Profit Q1 2026 · Mar 31, 2026 $42.83M
Gross Profit Q1 2026 · Mar 31, 2025 $33.28M
Cost Of Revenue Q1 2026 · Mar 31, 2026 $32.59M
Cost Of Revenue Q1 2026 · Mar 31, 2025 $25.85M
Revenue Q1 2026 · Mar 31, 2026 $75.41M
Revenue Q1 2026 · Mar 31, 2025 $59.13M